Interventions for valvular disease and heart failure

Coronary access techniques following ACURATE neo2 implantation in surgical bioprosthesis

EuroIntervention 2022;18:820-821. DOI: 10.4244/EIJ-D-22-00149

Arif Khokhar
Arif A. Khokhar1,2, BM, BCh; Francesco Ponticelli3, MD; Adriana Zlahoda-Huzior2,4, MSc; Pawel Zakrzewski2, MSc; Ghada Mikhail1, MD, FRCP; Dariusz Dudek5,6, PhD; Francesco Giannini5, MD
1. Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom; 2. Digital Innovations & Robotics Hub, Krakow, Poland; 3. Humanitas University, Rozzano, Italy; 4. Department of Measurement & Electronics, AGH University of Science & Technology, Krakow, Poland; 5. Interventional Cardiology Unit, GVM Care & Research, Maria Cecilia Hospital, Cotignola, Italy; 6. Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland
  Coronary access after transcatheter aortic valve implantation (TAVI) procedures can be challenging due to anatomical, procedural or valve-related factors12. This challenge is further augmented during valve-in-valve (ViV) procedures due to the additional presence of transcatheter or surgical valve frames and leaflets3. Dedicated valve-specific cannulation techniques are required for operators to achieve coronary access, particularly in challenging scenarios24. To date, specific coronary cannulation techniques have only been described for the CoreValve/Evolut (Medtronic) and SAPIEN (Edwards Lifesciences) valve platforms following native aortic valve TAVI24.

Therefore, we performed ex vivo simulations of coronary access in a computed tomography-derived patient-specific pulsatile ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Commissural alignment with the novel Hydra transcatheter heart valve during aortic valve replacement

Latest news